These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 9316509)

  • 1. Effectiveness of an antioxidant in preventing restenosis after percutaneous transluminal coronary angioplasty: the Probucol Angioplasty Restenosis Trial.
    Yokoi H; Daida H; Kuwabara Y; Nishikawa H; Takatsu F; Tomihara H; Nakata Y; Kutsumi Y; Ohshima S; Nishiyama S; Seki A; Kato K; Nishimura S; Kanoh T; Yamaguchi H
    J Am Coll Cardiol; 1997 Oct; 30(4):855-62. PubMed ID: 9316509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preventive effects of probucol on restenosis after percutaneous transluminal coronary angioplasty.
    Watanabe K; Sekiya M; Ikeda S; Miyagawa M; Hashida K
    Am Heart J; 1996 Jul; 132(1 Pt 1):23-9. PubMed ID: 8701872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of residual plaque burden after balloon angioplasty in the MultiVitamins and Probucol (MVP) trial.
    Tardif JC; Côté G; Lespérance J; Gosselin G; Joyal M; de Guise P; Bilodeau L; Doucet S; Harel F; Couturier A; Gallo R; Grégoire J
    Can J Cardiol; 2001 Jan; 17(1):49-55. PubMed ID: 11173314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of restenosis after coronary balloon angioplasty: rationale and design of the Fluvastatin Angioplasty Restenosis (FLARE) Trial. The FLARE Study Group.
    Foley DP; Bonnier H; Jackson G; Macaya C; Shepherd J; Vrolix M; Serruys PW
    Am J Cardiol; 1994 May; 73(14):50D-61D. PubMed ID: 8198025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of pravastatin on angiographic restenosis after coronary balloon angioplasty. The PREDICT Trial Investigators. Prevention of Restenosis by Elisor after Transluminal Coronary Angioplasty.
    Bertrand ME; McFadden EP; Fruchart JC; Van Belle E; Commeau P; Grollier G; Bassand JP; Machecourt J; Cassagnes J; Mossard JM; Vacheron A; Castaigne A; Danchin N; Lablanche JM
    J Am Coll Cardiol; 1997 Oct; 30(4):863-9. PubMed ID: 9316510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of probucol in preventing restenosis after percutaneous transluminal coronary angioplasty.
    Lee YJ; Daida H; Yokoi H; Miyano H; Takaya J; Sakurai H; Mokuno H; Yamaguchi H
    Jpn Heart J; 1996 May; 37(3):327-32. PubMed ID: 8774625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of probucol on repeat revascularization rate after percutaneous transluminal coronary angioplasty (from the Probucol Angioplasty Restenosis Trial [PART]).
    Daida H; Kuwabara Y; Yokoi H; Nishikawa H; Takatsu F; Nakata Y; Kutsumi Y; Oshima S; Nishiyama S; Ishiwata S; Kato K; Nishimura S; Miyauchi K; Kanoh T; Yamaguchi H
    Am J Cardiol; 2000 Sep; 86(5):550-2, A9. PubMed ID: 11009277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Probucol and multivitamins in the prevention of restenosis after coronary angioplasty. Multivitamins and Probucol Study Group.
    Tardif JC; Cöté G; Lespérance J; Bourassa M; Lambert J; Doucet S; Bilodeau L; Nattel S; de Guise P
    N Engl J Med; 1997 Aug; 337(6):365-72. PubMed ID: 9241125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Reduction in the rates of restenosis after coronary angioplasty with simvastatin and probucol].
    Merchán Herrera A; López Mínguez JR; Alonso Ruiz F; Escola JM; Címbora Ortega A; Poblador Curto MA; Redondo Méndez A; Romero Santisteban R; Geniz Gallardo I; González Fernández R; Millán Núñez V
    Rev Esp Cardiol; 1999 Oct; 52(10):778-84. PubMed ID: 10563153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of restenosis after angioplasty in small coronary arteries with probucol.
    Rodés J; Côté G; Lespérance J; Bourassa MG; Doucet S; Bilodeau L; Bertrand OF; Harel F; Gallo R; Tardif JC
    Circulation; 1998 Feb; 97(5):429-36. PubMed ID: 9490236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of cilostazol on restenosis after percutaneous coronary balloon angioplasty.
    Tsuchikane E; Fukuhara A; Kobayashi T; Kirino M; Yamasaki K; Kobayashi T; Izumi M; Otsuji S; Tateyama H; Sakurai M; Awata N
    Circulation; 1999 Jul; 100(1):21-6. PubMed ID: 10393676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Probucol therapy in the prevention of restenosis after successful percutaneous transluminal coronary angioplasty.
    Setsuda M; Inden M; Hiraoka N; Okamoto S; Tanaka H; Okinaka T; Nishimura Y; Okano H; Kouji T; Konishi T
    Clin Ther; 1993; 15(2):374-82. PubMed ID: 8519045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized placebo-controlled trial of fluvastatin for prevention of restenosis after successful coronary balloon angioplasty; final results of the fluvastatin angiographic restenosis (FLARE) trial.
    Serruys PW; Foley DP; Jackson G; Bonnier H; Macaya C; Vrolix M; Branzi A; Shepherd J; Suryapranata H; de Feyter PJ; Melkert R; van Es GA; Pfister PJ
    Eur Heart J; 1999 Jan; 20(1):58-69. PubMed ID: 10075142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of probucol on restenosis after percutaneous coronary intervention: a systematic review and meta-analysis.
    Liu J; Li M; Lu H; Qiao W; Xi D; Luo T; Xiong H; Guo Z
    PLoS One; 2015; 10(4):e0124021. PubMed ID: 25898372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Failure of epoprostenol (prostacyclin, PGI2) to inhibit platelet aggregation and to prevent restenosis after coronary angioplasty: results of a randomised placebo controlled trial.
    Gershlick AH; Spriggins D; Davies SW; Syndercombe Court YD; Timmins J; Timmis AD; Rothman MT; Layton C; Balcon R
    Br Heart J; 1994 Jan; 71(1):7-15. PubMed ID: 8297699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low molecular weight heparin (reviparin) in percutaneous transluminal coronary angioplasty. Results of a randomized, double-blind, unfractionated heparin and placebo-controlled, multicenter trial (REDUCE trial). Reduction of Restenosis After PTCA, Early Administration of Reviparin in a Double-Blind Unfractionated Heparin and Placebo-Controlled Evaluation.
    Karsch KR; Preisack MB; Baildon R; Eschenfelder V; Foley D; Garcia EJ; Kaltenbach M; Meisner C; Selbmann HK; Serruys PW; Shiu MF; Sujatta M; Bonan R
    J Am Coll Cardiol; 1996 Nov; 28(6):1437-43. PubMed ID: 8917255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of an acute reduction in lipoprotein(a) with coronary artery restenosis after percutaneous transluminal coronary angioplasty.
    Horie H; Takahashi M; Izumi M; Takaoka A; Fujita T; Sakamoto T; Kito O; Okamura H; Kinoshita M
    Circulation; 1997 Jul; 96(1):166-73. PubMed ID: 9236431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of probucol and cilostazol alone and in combination on frequency of poststenting restenosis.
    Sekiya M; Funada J; Watanabe K; Miyagawa M; Akutsu H
    Am J Cardiol; 1998 Jul; 82(2):144-7. PubMed ID: 9678282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Restenosis and clinical outcome in patients treated with amlodipine after angioplasty: results from the Coronary AngioPlasty Amlodipine REStenosis Study (CAPARES).
    Jørgensen B; Simonsen S; Endresen K; Forfang K; Vatne K; Hansen J; Webb J; Buller C; Goulet G; Erikssen J; Thaulow E
    J Am Coll Cardiol; 2000 Mar; 35(3):592-9. PubMed ID: 10716459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of AGI-1067 and probucol after percutaneous coronary interventions.
    Tardif JC; Grégoire J; Schwartz L; Title L; Laramée L; Reeves F; Lespérance J; Bourassa MG; L'Allier PL; Glass M; Lambert J; Guertin MC;
    Circulation; 2003 Feb; 107(4):552-8. PubMed ID: 12566365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.